DAWN Len Blavatnik buys $14.0M worth of shares
Jan 01, 2026, 5:39 PM
0.00%
What does DAWN do
Day One Biopharmaceuticals, based in Brisbane, California, focuses on developing cancer treatments, including its lead candidate tovorafenib. The company went public on May 27, 2021, and employs 174 people.
Len Blavatnik bought 875,000 shares of DAWN on 1 June at $16.00 per share, worth a total of $14.0M. They now own 9,377,776 DAWN shares, or a 10% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.